Diabetes-induced hepatic oxidative stress: a new pathogenic role for glycated albumin

Archive ouverte

Patche, Jessica | Girard, Dorothée | Catan, Aurélie | Boyer, Florence | Dobi, Anthony | Planesse, Cynthia | Diotel, Nicolas | Guerin-Dubourg, Alexis | Baret, Pascal | Bravo, Susana B. | Paradela-Dobarro, Beatriz | Álvarez, Ezequiel | Essop, M. Faadiel | Meilhac, Olivier | Bourdon, Emmanuel | Rondeau, Philippe

Edité par CCSD ; Elsevier -

International audience. Increased oxidative stress and advanced glycation end-product (AGE) formation are major contributors to the development of type 2 diabetes. Here plasma proteins e.g. albumin can undergo glycoxidation and play a key role in diabetes onset and related pathologies. However, despite recent progress linking albumin-AGE to increased oxidative stress and downstream effects, its action in metabolic organs such as the liver remains to be elucidated. The current study therefore investigated links between oxidative perturbations and biochemical/structural modifications of plasma albumin, and subsequent downstream effects in transgenic db/db mouse livers and HepG2 cells, respectively. Our data reveal increased oxidative stress biomarkers and lipid accumulation in plasma and livers of diabetic mice, together with albumin glycoxidation. Purified mouse albumin modifications resembled those typically found in diabetic patients, i.e. degree of glycation, carbonylation, AGE levels and in terms of chemical composition. Receptor for AGE expression and reactive oxygen species production were upregulated in db/db mouse livers, together with impaired proteolytic, antioxidant and mitochondrial respiratory activities. In parallel, acute exposure of HepG2 cells to glycated albumin also elicited intracellular free radical formation. Together this study demonstrates that AGE-modified albumin can trigger damaging effects on the liver, i.e. by increasing oxidative stress, attenuating antioxidant capacity, and by impairment of hepatic proteolytic and respiratory chain enzyme activities.

Suggestions

Du même auteur

Glycation of human serum albumin impairs binding to the glucagon-like peptide-1 analogue liraglutide

Archive ouverte | Gajahi Soudahome, Angélique | CCSD

International audience. The long-acting glucagon-like peptide-1 analogue liraglutide has proven efficiency in the management of type 2 diabetes and also has beneficial effects on cardiovascular diseases. Liraglutide...

Aging and glycation promote erythrocyte phagocytosis by human endothelial cells: Potential impact in atherothrombosis under diabetic conditions

Archive ouverte | Catan, Aurélie | CCSD

International audience. Background and aims: Atherothrombotic plaques of type 2 diabetic (T2D) patients are characterized by an increased neovascularization and intraplaque hemorrhage. The clearance of erythrocytes ...

Advanced glycation end-products disrupt human endothelial cells redox homeostasis: new insights into reactive oxygen species production

Archive ouverte | Dobi, Anthony | CCSD

International audience. During diabetes mellitus, advanced glycation end-products (AGEs) are major contributors to the development of alterations in cerebral capillaries, leading to the disruption of the blood-brain...

Chargement des enrichissements...